Fuso Pharmaceutical Industries Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuso Pharmaceutical Industries Ltd with three other
companies in this sector in JAPAN :
Aska Pharmaceutical Company Limited
sales of 52.54 billion Japanese Yen [US$497.05 million]
of which 91%
was Pharmaceutical Products Business),
Zeria Pharmaceutical Co Ltd
(60.43 billion Japanese Yen [US$571.64 million]
of which 53%
was Pharmaceuticals Business), and
Eiken Chemical Co., Ltd.
(36.59 billion Japanese Yen [US$346.09 million]
of which 55%
was Immunoserology Test Agent).
During the year ended March of 2020, sales at
Fuso Pharmaceutical Industries Ltd were ¥46.90 billion (US$443.68 million).
a very small
increase of 1.8%
versus 2019, when the company's sales were ¥46.07 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Fuso Pharmaceutical Industries Ltd had sales
of ¥47.04 billion.